Your browser doesn't support javascript.
loading
Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients.
Ramos-Campoy, Silvia; Puiggros, Anna; Beà, Sílvia; Bougeon, Sandrine; Larráyoz, María José; Costa, Dolors; Parker, Helen; Rigolin, Gian Matteo; Ortega, Margarita; Blanco, María Laura; Collado, Rosa; Salgado, Rocío; Baumann, Tycho; Gimeno, Eva; Moreno, Carolina; Bosch, Francesc; Calvo, Xavier; Calasanz, María José; Cuneo, Antonio; Strefford, Jonathan C; Nguyen-Khac, Florence; Oscier, David; Haferlach, Claudia; Schoumans, Jacqueline; Espinet, Blanca.
Afiliación
  • Ramos-Campoy S; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar, Barcelona, Spain; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.
  • Puiggros A; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar, Barcelona, Spain; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain. apuiggros@imim.es.
  • Beà S; Hematopathology Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERONC, Barcelona, Spain.
  • Bougeon S; Oncogenomic Laboratory, Hematology Service, Lausanne University Hospital, Lausanne, Switzerland.
  • Larráyoz MJ; Cytogenetics and Hematological Genetics Services, Department of Genetics, University of Navarra, Pamplona, Spain.
  • Costa D; Hematopathology Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERONC, Barcelona, Spain.
  • Parker H; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Rigolin GM; Hematology Section, St. Anna University Hospital, Ferrara, Italy.
  • Ortega M; Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.
  • Blanco ML; Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Collado R; Department of Hematology, Consorcio Hospital General Universitario, Valencia, Spain.
  • Salgado R; Cytogenetics Laboratory, Hematology Department, Fundación Jiménez Díaz, Madrid, Spain.
  • Baumann T; Hematopathology Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERONC, Barcelona, Spain.
  • Gimeno E; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar, Barcelona, Spain; Applied Clinical Research in Hematological Malignances, Cancer Research Program, IMIMHospital del Mar, Barcelona, Spain.
  • Moreno C; Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Bosch F; Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.
  • Calvo X; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar, Barcelona, Spain; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.
  • Calasanz MJ; Cytogenetics and Hematological Genetics Services, Department of Genetics, University of Navarra, Pamplona, Spain.
  • Cuneo A; Hematology Section, St. Anna University Hospital, Ferrara, Italy.
  • Strefford JC; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Nguyen-Khac F; Hematology Department and Sorbonne Université, Hopital Pitie-Salpetriere, APHP, INSERM U1138, Paris, France.
  • Oscier D; Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Haferlach C; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Schoumans J; Oncogenomic Laboratory, Hematology Service, Lausanne University Hospital, Lausanne, Switzerland.
  • Espinet B; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar, Barcelona, Spain; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain. bespinet@parcdesalutmar.cat.
Haematologica ; 107(3): 593-603, 2022 03 01.
Article en En | MEDLINE | ID: mdl-33691382
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Italia